Cargando…

Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?

Crohn’s Disease (CD) results from inappropriate response toward commensal flora. Earlier studies described CD as a Th1 mediated disease. Current models view both phenotypes as a continuum of various permutations between Th1, Th2 and Th17 pathways compounded by a range of Treg disfunctions. In the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Wing-Cheong, Arsenescu, Violeta, Arsenescu, Razvan I., Friedman, Avner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100971/
https://www.ncbi.nlm.nih.gov/pubmed/27824890
http://dx.doi.org/10.1371/journal.pone.0165782
_version_ 1782466226517180416
author Lo, Wing-Cheong
Arsenescu, Violeta
Arsenescu, Razvan I.
Friedman, Avner
author_facet Lo, Wing-Cheong
Arsenescu, Violeta
Arsenescu, Razvan I.
Friedman, Avner
author_sort Lo, Wing-Cheong
collection PubMed
description Crohn’s Disease (CD) results from inappropriate response toward commensal flora. Earlier studies described CD as a Th1 mediated disease. Current models view both phenotypes as a continuum of various permutations between Th1, Th2 and Th17 pathways compounded by a range of Treg disfunctions. In the present paper, we develop a mathematical model, by a system of differential equations, which describe the dynamic relations among these T cells and their cytokines. The model identities four groups of CD patients according to up/down regulation of Th1 and Th2. The model simulations show that immunosuppression by TNF-α blockage benefits the group with Th1(High)/Th2(Low) while, by contrast, the group with Th1(Low)/Th2(High) will benefit from immune activation.
format Online
Article
Text
id pubmed-5100971
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51009712016-11-18 Inflammatory Bowel Disease: How Effective Is TNF-α Suppression? Lo, Wing-Cheong Arsenescu, Violeta Arsenescu, Razvan I. Friedman, Avner PLoS One Research Article Crohn’s Disease (CD) results from inappropriate response toward commensal flora. Earlier studies described CD as a Th1 mediated disease. Current models view both phenotypes as a continuum of various permutations between Th1, Th2 and Th17 pathways compounded by a range of Treg disfunctions. In the present paper, we develop a mathematical model, by a system of differential equations, which describe the dynamic relations among these T cells and their cytokines. The model identities four groups of CD patients according to up/down regulation of Th1 and Th2. The model simulations show that immunosuppression by TNF-α blockage benefits the group with Th1(High)/Th2(Low) while, by contrast, the group with Th1(Low)/Th2(High) will benefit from immune activation. Public Library of Science 2016-11-08 /pmc/articles/PMC5100971/ /pubmed/27824890 http://dx.doi.org/10.1371/journal.pone.0165782 Text en © 2016 Lo et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lo, Wing-Cheong
Arsenescu, Violeta
Arsenescu, Razvan I.
Friedman, Avner
Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
title Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
title_full Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
title_fullStr Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
title_full_unstemmed Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
title_short Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
title_sort inflammatory bowel disease: how effective is tnf-α suppression?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100971/
https://www.ncbi.nlm.nih.gov/pubmed/27824890
http://dx.doi.org/10.1371/journal.pone.0165782
work_keys_str_mv AT lowingcheong inflammatoryboweldiseasehoweffectiveistnfasuppression
AT arsenescuvioleta inflammatoryboweldiseasehoweffectiveistnfasuppression
AT arsenescurazvani inflammatoryboweldiseasehoweffectiveistnfasuppression
AT friedmanavner inflammatoryboweldiseasehoweffectiveistnfasuppression